Jacques Rachelle Suzanne

CIK 00017726104 companiesAMSTERDAM

SEC Profile

Transactions

Companies

Filings

CIK

0001772610

Recent Transactions

37 trades

Sale
uniQure N.V.$QURE
Ordinary Shares
2026-06-11$27.06/sh−1,993→ 33,903 total
Award
uniQure N.V.$QURE
Ordinary Shares
2026-06-10+7,550→ 35,896 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2026-06-10+13,980→ 13,980 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock options (right to buy)
2026-05-19+12,300→ 12,300 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Common Stock, par value $0.0001 per share
2026-05-19+3,800→ 11,383 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2025-06-20$14.45/sh−2,112→ 28,346 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2025-06-11+15,630→ 15,630 total
Award
uniQure N.V.$QURE
Ordinary Shares
2025-06-11+7,970→ 30,458 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock options (right to buy)
2025-05-30+16,000→ 16,000 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Common Stock, par value $0.0001 per share
2025-05-30+4,800→ 7,583 total
Award
uniQure N.V.$QURE
Ordinary Shares
2024-06-19+8,080→ 22,488 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2024-06-19+15,840→ 15,840 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2024-06-13$5.14/sh−2,221→ 14,408 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Common Stock, par value $0.0001 per share
2024-05-30+2,783→ 2,783 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option (right to buy)
2024-05-16+2,783→ 2,783 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-04-26+479,569,892→ 1,018,027,792 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2023-06-16$18.76/sh−2,301→ 16,629 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2023-06-13+17,060→ 17,060 total
Award
uniQure N.V.$QURE
Ordinary Shares
2023-06-13+8,700→ 18,930 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option (right to buy)
2023-05-18+5,300→ 5,300 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2023-02-27$20.02/sh−384→ 10,230 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2022-06-15+17,810→ 17,810 total
Award
uniQure N.V.$QURE
Ordinary Shares
2022-06-15+9,080→ 10,614 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2022-05-18+79,600→ 79,600 total
Award
uniQure N.V.$QURE
Ordinary Shares
2022-02-24+1,534→ 1,534 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2022-02-24+2,645→ 2,645 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2021-10-21+10,000→ 10,000 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option (right to buy)
2021-06-17+58,200→ 58,200 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option (right to buy)
2021-06-17+58,200→ 58,200 total
Disposition to Issuer
Viela Bio, Inc.
Stock Option (right to buy)
2021-03-15−7,358→ 0 total
Disposition to Issuer
Viela Bio, Inc.
Stock Option (right to buy)
2021-03-15−14,716→ 0 total
Award
Viela Bio, Inc.
Stock Option (right to buy)
2020-06-19+14,716→ 14,716 total
Award
Viela Bio, Inc.
Stock Option (Right to Buy)
2020-06-19+14,716→ 14,716 total
Award
Viela Bio, Inc.
Stock Option (Right to Buy)
2020-06-19+7,358→ 7,358 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2020-05-20+40,500→ 40,500 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2019-05-22+33,300→ 33,300 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2019-04-05+68,000→ 68,000 total

Companies

Recent Filings

Address

C/O UNIQURE N. V. PAASHEUVELWEG 25A

AMSTERDAM, 1105BP

View on SEC.gov